By the age of four months, the retinas of mice carrying a mutation in the gene encoding PDE6? (left) are thin and lack rod photoreceptors (red). But mice who have had this mutation corrected through the PESpRY system (right) have much thicker retinas containing numerous rod cells.
CREDIT: Qin et al. Originally published in Journal of Experimental Medicine. https://doi.org/10.1084/jem.20220776
Researchers in China have successfully restored the vision of mice with retinitis pigmentosa, one of the major causes of blindness in humans. The study, to be published March 17 in the Journal of Experimental Medicine, uses a new, highly versatile form of CRISPR-based genome editing with the potential to correct a wide variety of disease-causing genetic mutations.
Researchers have previously used genome editing to restore the vision of mice with genetic diseases, such as Leber congenital amaurosis, that affect the retinal pigment epithelium, a layer of non-neuronal cells in the eye that supports the light-sensing rod and cone photoreceptor cells. However, most inherited forms of blindness, including retinitis pigmentosa, are caused by genetic defects in the neural photoreceptors themselves.
“The ability to edit the genome of neural retinal cells, particularly unhealthy or dying photoreceptors, would provide much more convincing evidence for the potential applications of these genome-editing tools in treating diseases such as retinitis pigmentosa,” says Kai Yao, a professor at the Wuhan University of Science and Technology.
Retinitis pigmentosa can be caused by mutations in over 100 different genes and is estimated to impair the vision of 1 in 4,000 people. It begins with the dysfunction and death of dim light-sensing rod cells, before spreading to the cone cells required for color vision, eventually leading to severe, irreversible vision loss.
Yao and colleagues attempted to rescue the vision of mice with retinitis pigmentosa caused by a mutation in the gene encoding a critical enzyme called PDE6?. To do this, Yao’s team developed a new, more versatile CRISPR system called PESpRY, which can be programmed to correct many different types of genetic mutation, regardless of where they occur within the genome.
When programmed to target the mutant PDE6? gene, the PESpRY system was able to efficiently correct the mutation and restore the enzyme’s activity in the retinas of mice. This prevented the death of rod and cone photoreceptors and restored their normal electrical responses to light.
Yao and colleagues performed a variety of behavioral tests to confirm that the gene-edited mice retained their vision even into old age. For example, the animals were able to find their way out of a visually guided water maze almost as well as normal, healthy mice and showed typical head movements in response to visual stimuli.
Yao cautions that much work still needs to be done to establish both the safety and efficacy of the PESpRY system in humans. “However, our study provides substantial evidence for the in vivo applicability of this new genome-editing strategy and its potential in diverse research and therapeutic contexts, in particular for inherited retinal diseases such as retinitis pigmentosa,” Yao says.
Original Article: New gene-editing technique reverses vision loss in mice
More from: Wuhan University of Science and Technology
The Latest Updates from Bing News
Go deeper with Bing News on:
- 2023 to 2030 Retinitis Pigmentosa Treatment Market Regional Outlook
The MarketWatch News Department was not involved in the creation of this content. Mar 24, 2023 (The Expresswire) -- “Retinitis Pigmentosa Treatment Market” Are a Collection of Information and Analysis ...
- Gene editing restores vision in mice with retinitis pigmentosa
A modification of the CRISPR technique has made it possible to restore vision in mouse models with retinitis pigmentosa (RP). Scientists at the Institute of Visual Neuroscience and Stem Cell ...
- Prime Editing Reverses Vision Loss in Mice
The inherited retinal disease, retinitis pigmentosa (RP)—marked by progressive and irreversible loss of retinal photoreceptors—is a major cause of blindness in humans. Now, researchers have ...
- New Form of CRISPR Reverses Vision Loss in Mice
A new, highly versatile form of CRISPR has been used to restore vision in mice with retinitis pigmentosa, one of the major causes of blindness in humans.
- Retinitis Pigmentosa (Retinitis) Market Size 2023: Industry Forecast to 2030
Market Reports World Published a New Report on "Retinitis Pigmentosa (Retinitis) Market" [NEW FORECAST REPORT] ...
Go deeper with Bing News on:
- Gallium Antimonide Wafer Market Outlook By 2031
The "Gallium Antimonide Wafer Market" Study Describes how the technology industry is evolving and how major and ...
- Nvidia unveils Isaac Sim on Omniverse Cloud for better robot design
Nvidia has unveiled its Isaac Sim platform for its Omniverse Cloud, enabling engineers to work together remotely to simulate robots ...
- ROHM Establishes Ultra-High-Speed Control IC Technology that Maximizes the Performance of GaN Devices
ROHM Semiconductor today introduced ultra-high-speed control IC technology that maximizes the performance of GaN and other high-speed switching ...
- I Saw the Face of God in a Semiconductor Factory
As the US boosts production of silicon chips, an American journalist goes inside TSMC, the mysterious Taiwanese company at the center of the global industry.
- Cellular waste removal differs according to cell type, finds study
"Miniature shredders" are at work in each cell, disassembling and recycling cell components that are defective or no longer required. The exact structure of these shredders differs from cell type to ...